Quick Answer
REGENXBIO Inc. reported Operating Income of -$161.20 million for fiscal year 2025.
REGENXBIO Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$161.20M | +30.9% |
| 2024 | -$233.35M | +13.0% |
| 2023 | -$268.13M | -2.0% |
| 2022 | -$262.88M | -264.3% |
| 2021 | $159.98M | +234.2% |
| 2020 | -$119.23M | +20.0% |
| 2019 | -$149.00M | -269.1% |
| 2018 | $88.10M | +216.1% |
| 2017 | -$75.89M | -16.1% |
| 2016 | -$65.34M | -182.4% |
| 2015 | -$23.14M | -528.4% |
| 2014 | -$3.68M | +22.9% |
| 2013 | -$4.78M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$52.41M | +15.6% | +17.2% |
| June 30, 2025 | -$63.28M | -12.9% | -621.8% |
| March 31, 2025 | $12.13M | +119.0% | +119.5% |
| September 30, 2024 | -$62.08M | +4.4% | -10.8% |
| June 30, 2024 | -$56.04M | +23.4% | +12.3% |
| March 31, 2024 | -$63.86M | +3.5% | +1.7% |
| September 30, 2023 | -$64.96M | +8.6% | +11.1% |
| June 30, 2023 | -$73.11M | -16.9% | -10.5% |
- REGENXBIO Inc. showed an increase of +30.9% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, REGENXBIO Inc.’s operating income has declined by 3275.2% (from -$4.78 million to -$161.20 million).
- The most recent figure is from REGENXBIO Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: